Stafford, Sara http://orcid.org/0000-0002-1551-6208
Bech, Peter G.
Fridhammar, Adam
Miresashvili, Nino
Nilsson, Andreas
Willis, Michael
Liu, Aiden
Funding for this research was provided by:
Novo Nordisk Canada Inc.
Article History
Accepted: 27 February 2022
First Online: 28 March 2022
Change Date: 20 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40258-022-00734-z
Declarations
:
: Sponsorship for this analysis and article processing charges was provided by Novo Nordisk Canada Inc. The sponsor participated in the study design and the collection, analysis, and interpretation of data. Three of the authors of this manuscript are employees of the sponsor and, as such, were involved in the preparation, review, approval, and decision for submission of the manuscript.
: SS has received continuing medical education honoraria from Novo Nordisk, Boehringer Ingelheim, Lilly, Sanofi, Janssen, AstraZeneca, Medtronic, Tandem, Abbott, Dexcom, CCRN, CPD Network, and MD Briefcase; participated in advisory boards for Novo Nordisk, Boehringer Ingelheim, Lilly, Sanofi, Janssen, AstraZeneca, and Abbott; and received research support from Sanofi, AstraZeneca, and Novo Nordisk. AL is an employee of Novo Nordisk Canada Inc. PB is an employee and shareholder of Novo Nordisk Canada Inc. AF and AN are employees of, and MW is an employee, minority owner, and unpaid director of the Swedish Institute for Health Economics, which provides consulting services for governmental bodies, academic institutions, and commercial life science enterprises, including Novo Nordisk A/S. The Swedish Institute for Health Economics owns the ECHO-T2DM and IHE-DCM, used in this analysis. The Swedish Institute for Health Economics is owned principally by the non-profit Bengt Jönsson Foundation for Health Economic Research. NM is an employee of Novo Nordisk A/S.
: The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
: The IHE-DCM [CitationRef removed] and the ECHO-T2DM are described in detail in Appendix A in the ESM and elsewhere in the literature [CitationRef removed–CitationRef removed].<b>Author contribution statement</b>SS is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis. All authors confirm that they meet the International Committee of Medical Journal Editors uniform requirements for authorship and that they have contributed to the critical analysis and interpretation of the data and drafting and/or critically revising the article and share the final responsibility for the content of the manuscript and the decision to submit it for publication.
: The SUSTAIN 8 trial was performed in compliance with the International Conference on Harmonisation Good Clinical Practice Guidelines and the Declaration of Helsinki. Prior to trial initiation, the protocol, the consent form, and the patient information sheet were reviewed and approved according to local regulations by appropriate health authorities and by an independent ethics committee/institutional review board.
: All patients provided written informed consent for trial participation.
: All patients provided written informed consent for publication of their data.
: This article does not contain any new studies with human or animal subjects performed by any of the authors.